S.I.S. INTERNATIONAL SCHOOL OF SENOLOGY S.I.S. / I.S.S.

Transcription

1 REGISTRE DES ASSOCIATIONS TRIBUNAL DE STRASBOURG VOLUME 35, No. 58. SOCIEDAD INTERNACIONAL DE SENOLOGIA. Jaime Roig 18, Puerta Valencia. España. NIF Código Electrónico EA9FCBBBD4E S.I.S. INTERNATIONAL SCHOOL OF SENOLOGY S.I.S. / I.S.S. Dear S.I.S. Members, We are glad to inform you on the S.I.S. / I.S.S. activity which was held in Bangalore, India, on March 3-4, 2012, in the framework of the 3 rd. Asian Breast Cancer Congress. Dr.Vineet Gupta, President of the Congress, kindly invited SIS / ISS to participate in this event. Prof. Ruben Orda, Director of the SIS/ISS, and Dr. Mauricio Magalhaes Costa, Presidential Ad-Hoc Committee Member of the SIS, actively participated in the Scientific Program (see attached document) and spread out information on the SIS/ISS goals, activities and projects, among the numerous participants. We hearty congratulate Dr. Vineet Gupta for the successful organization of the Congress and greatly thank him for his kind and warm hospitality. Prof. Ruben Orda Director SIS/ISS Dr. Carlos Garbino Secretary SIS/ISS

2 3 rd Asian Breast Cancer Congress Scientific Program 3 4 March 2012, Bangalore, India Saturday, 3 March :00 1:00 pm Lunch and Registration Session B 1 1:00 2:30 pm Is Breast Cancer in the Developing World an Orphan Disease? Chair: Co-Chair: R Badwe 1:00 1:30 pm Scope of the Problem in Developing World Natco 1:30 2:30 pm Panel Discussion Panelists: M Costa, DC Doval, C Goswami, PK Julka, S Nag, E Novais Session B 2 2:30 4:00 pm Seeing is Believing: Imaging & Pathology Chair: A Agarwal Co Chair: 2:30 2:45 pm Optimal Screening Strategies in Developing Countries R Nimmagadda 2:45 3:00 pm Pathology Standards in Developing Countries J Simon 3:00 4:00 pm Panel Discussion Panelists: RT Chacko, S Gupta, D Hazarika,, A Pais Session B 3 4:00 5:00 pm Supportive Oncology and Quality Standards in Breast Cancer Care Chair: J Harris Co Chair: S Patil Ranbaxy 4:00 4:20 pm Patient Centric Care in Breast Cancer 4:20 4:40 pm SIS/ISS International Program of Accreditation of Breast Centers R Orda 4:40 5:00 pm Panel Discussion Panelists: KS Gopinath, U Mayya, A Munshi, V Parmar Session B :20 pm My Journey: From an Oncologist to an Entrepreneur BS Ajaikumar 5:20 5:30 pm Coffee Break Partner s *This program has the American Society of Clinical Oncology s approval for quality of educational content. ASCO endorsement does not constitute medical advice. Health care providers should exercise their own independent judgment. **This program has been awarded 15 ESMO-MORA cat. 1 points by the ESMO ECWG.

3 Session B 5 5:30 6:15 pm Genomics Made Simple Chair: Co Chair: S Nag Genomic Health 5:30 5:45 pm Development and Assessment of Gene Expressions Profile Technology 5:45 6:00 pm Applying genomic test in the clinic: What every oncologist should know but may be doesn t? 6:00 6:15 pm Panel Discussion Panelists: S Agarwal, GS Bhattacharya, S Dattatreya, A Goel, H Malhotra Session B 6 6:15 7:30 pm Neoadjuvant Therapy in Breast Cancer Chair: S Agarwal Co Chair: S Zaveri 6:15 6:30 pm Neoadjuvant Chemotherapy : Promise and Peril Agila A Strides Enterprise 6:30 6:45 pm Surgical Issues in Neoadjuvant Chemotherapy 6:45 7:00 pm Adjuvant treatment after partial response to chemotherapy in Neoadjuvant setting S Gupta 7:00 7:15 pm Radiation after Neoadjuvant Chemotherapy J Harris 7:15 7:30 pm Panel Discussion Panelists: G Agarwal, P Patil Session B 7 7:30 8:30 pm Targeted Therapy in Breast Cancer Chair: A K Vaid Co Chair: R Nimmagadda 7:30 7:50 pm State- of-the Art Management of HER2+ Early Breast Cancer 7:50 8:10 pm State- of -the Art Management of HER2 + Metastatic Breast Cancer 8:10 8:30 pm Panel Discussion and QA Panelists: C Goswami, R Rao, S Patil 8:30 pm Gala Dinner

4 Sunday, 4 March :30 8:00 am Registration Session B 8 8:00 9:00 am Endocrine Therapy in Breast Cancer Chair: Co-Chair: DC Doval, PK Julka 8:00 8:20 am Maximizing efficacy of adjuvant endocrine therapy in post menopausal early breast cancer R Badwe 8:20 8:40 am Management of post menopausal ER(+) advanced breast cancer S Gupta 8:40 9:00 am Q & A Session B 9 9:00 9:30 am Radiation Therapy in Breast Cancer Chair: G K Rath Co Chair: S Sharma 9:00 9:20 am Radiation Therapy in Breast Cancer. Quo vadis? J Harris Session B 10 9:30 10:15 am 3rd ABCC Oration Biology-driven selection of combined modality therapeutic strategies for advanced breast cancer 10:15 10:30 am Coffee Break Session B 11 10:30 11:30 am Adjuvant Therapy in Breast Cancer Chair: Co Chair: S Sriniwas Intas Biopharmaceuticals 10:30 10:50 am Poor Prognosis ER + Breast Cancer 10:50 11:30 am Panel Discussion Panelists: S Dattatreya, S Gupta,V Parmar, G Ramanan, NK Warrier Session B 12 11:30 am 12:30 pm Metastatic Breast Cancer Chair: T Raja Co Chair: N Kilara 11:30 11:45 am ESO (Lisbon) Guidelines for Advanced Breast Cancer O Pagani 11:45 12:00 pm Dilemmas in Chemotherapy for Metastatic Breast Cancer : An Overview 12:00 12:15 pm Emerging Therapies in Metastatic Breast Cancer 12:15 12:30 pm Panel Discussion Panelists: G Babu, S Gupta, AK Vaid

5 Session B 13 12:30 01:15 pm Survivorship Issues in Breast Cancer Chair: RT Chacko Co Chair: R Nimmagadda 12:30 12:40 pm Bone Health in Breast Cancer O Pagani 12:40 12:50 pm Weight Gain Diet and Physical Activity in Breast Cancer Survivors R Chauhan 12:50 1:00 pm Long Term Follow Up Guidelines in Survivors 01:00 1:15 pm Panel Discussion Panelists: RB Diwaker, KC Lakshmaiah 01:15 2:00 pm Lunch Break Session B 14 2:00 3:00 pm Surgery in Breast Cancer Chair: KS Gopinath Co Chair: M Vamsy 2:00 2:20 pm Future of Breast Cancer Surgery 2:20 2:40 pm Does a (+) SLN require Completion Axillary Lymph Node Dissection Yes: R Badwe No: A Costa 2:40 3:00 pm Panel Discussion Panelists: V Parmar, BS Srinath, S Somashekhar Session B 15 3:00 3:30 pm Everyday Statistics Chair: GS Bhattacharya Co Chair: H Malhotra 3:00 3:25pm Interpreting and Applying Clinical Trials in Breast Oncology 3:30 3:45 pm Coffee Break Session B 16 3:45 4:45 pm Real Life Debates Moderators: V Parmar, B Sirohi Session B 17 4:45 5:15 pm Futurama Chair: Co Chair: BS Ajaikumar 4:45 5:00 pm Where is Breast Oncology Headed? 5:00 5:15 pm Panel Discussion Panelists: RB Diwaker, A Munshi, A Ramesh, S Somashekhar Session B 18 5:15 5:30 pm Program Pearls Take Home Messages 5:30 pm Closing Novartis Dr. Reddy s Sun Oncology Sanofi Aventis Zydus Cadila